Last reviewed · How we verify
NCT06684132
Respiratory Muscle Training in Scleroderma
NA trial testing Inspiratory muscle training in Scleroderma (Limited and Diffuse) in 30 participants. Not yet recruiting.
10 January 2025
Quick facts
| Lead sponsor | Firat University |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 10 November 2024 |
| Primary completion | 10 January 2025 |
| Estimated completion | 20 February 2025 |
Drugs / interventions tested
- Inspiratory muscle training
- Exercise
Conditions studied
- Scleroderma (Limited and Diffuse) — all drugs for Scleroderma (Limited and Diffuse) →
Sponsor
Firat University
Who can join
Adults 18 to 65, any sex, with Scleroderma (Limited and Diffuse). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to investigate the effects of IMT on respiratory muscle strength, pulmonary function tests, quality of life aerobic capacity, dyspnea, fatigue and physical activity level in scleroderma patients with ILD. The study will include 30 Scleroderma + ILD patients who are under follow-up in Fırat University Rheumatology Department. Patients will be randomly divided into two groups. High intensity intermittent inspiratory muscle training (H-IMT) will be applied to the respiratory muscle training group in addition to the exercise program. Respiratory muscle strength will be assessed by maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP); aerobic capacity will be assessed by exercise test and VO2max. Dyspnea will be assessed with the Modified Medical Research Council Scale; fatigue with the Fatigue Severity Scale; quality of life with the Scleroderma Health Assessment Questionnaire; physical activity level with the International Physical Activity Scale - Short Form
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06684132
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Inspiratory muscle training
Trials testing the same drug.
- NCT07447037 — Integrating Aerobic, Respiratory, and Cognitive Training in Acute Heart Failure · NA · not yet recruiting
- NCT07386444 — Inspiratory Muscle Training for Breast Cancer Patients on Chemotherapy · NA · recruiting
- NCT07289958 — Effects of Respiratory Muscle Training in Post-bariatric Surgery Patients · NA · recruiting
- NCT07413718 — Inspiratory Muscle Training in Amiotrophyc Lateral Sclerosis · NA · recruiting
- NCT07104357 — The Effect of Inspiratory Muscle Training on Breathing Pattern and Functionality in Patients With Chronic Heart Failure. · NA · not yet recruiting
Other recruiting trials for Scleroderma (Limited and Diffuse)
Currently open trials in the same condition.
- NCT07292961 — Investigating the Effectiveness of the Biopsychosocial Model-Based Exercise Approach in Children and Adults Diagnosed Wi · NA · recruiting
Other Firat University trials
Trials by the same sponsor.
- NCT07520799 — The Effect of Mindfulness-Based Breathing Exercises on Dyspnea, Symptom Control, and Quality of Life in Lung Cancer Pati · NA · not yet recruiting
- NCT07520773 — Therapeutic Touch on Sleep, Comfort, and Physiological Parameters in Intensive Care Patients · NA · not yet recruiting
- NCT07521995 — Impact of Exercise Training on Serum Glial Fibrillary Acidic Protein (GFAP), Brain Volumetry, and Functional Outcomes in · NA · not yet recruiting
- NCT07520812 — Impact of Exercise Training on Serum Neurofilament Light Chain (NfL), Brain Volumetry, and Functional Outcomes in Multip · NA · not yet recruiting
- NCT07524231 — Evaluation of the Effects of Laughter Yoga · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06684132 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Firat University
- Last refreshed: 12 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06684132.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing